Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Celularity (CELU) Total Liabilities (2020 - 2025)

Celularity (CELU) has disclosed Total Liabilities for 6 consecutive years, with $134.3 million as the latest value for Q3 2025.

  • On a quarterly basis, Total Liabilities rose 20.41% to $134.3 million in Q3 2025 year-over-year; TTM through Sep 2025 was $134.3 million, a 20.41% increase, with the full-year FY2024 number at $123.8 million, up 20.32% from a year prior.
  • Total Liabilities was $134.3 million for Q3 2025 at Celularity, down from $145.8 million in the prior quarter.
  • In the past five years, Total Liabilities ranged from a high of $352.1 million in Q3 2021 to a low of $39.8 million in Q1 2021.
  • A 5-year average of $173.0 million and a median of $134.3 million in 2025 define the central range for Total Liabilities.
  • Peak YoY movement for Total Liabilities: skyrocketed 3112.99% in 2021, then crashed 54.18% in 2023.
  • Celularity's Total Liabilities stood at $314.7 million in 2021, then plummeted by 35.76% to $202.2 million in 2022, then tumbled by 49.09% to $102.9 million in 2023, then grew by 20.32% to $123.8 million in 2024, then increased by 8.47% to $134.3 million in 2025.
  • Per Business Quant, the three most recent readings for CELU's Total Liabilities are $134.3 million (Q3 2025), $145.8 million (Q2 2025), and $134.4 million (Q1 2025).